Retina Synthesis

147 Episodo

1. 18 Month Results of the Derby and Oaks Trials for Treatment of Geographic Atrophy

   Publicado: 4/8/2022
2. A Novel Retinal Sealant

   Publicado: 28/7/2022
3. New Developments in Imaging and Therapy of Sickle Cell Retinopathy

   Publicado: 21/7/2022
4. High Dose (8mg) Aflibercept for Treatment of Neovascular AMD

   Publicado: 7/7/2022
5. New Developments in the Management of Choroidal Melanoma

   Publicado: 30/6/2022
6. A Stem Cell Implant for the Treatment of Geographic Atrophy

   Publicado: 23/6/2022
7. DERBY and OAKS Results

   Publicado: 16/6/2022
8. Artificial Intelligence in the Management of Macular Degeneration

   Publicado: 9/6/2022
9. An Oral Agent for the Treatment of Diabetic Retinopathy

   Publicado: 2/6/2022
10. Home OCT Monitoring of Neovascular AMD Treatment

    Publicado: 26/5/2022
11. Faricimab in Diabetic Macular Edema: 2 Year Results of the RHINE and YOSEMITE studies

    Publicado: 19/5/2022
12. The Kingfisher Trial of Brolucizumab for DME

    Publicado: 12/5/2022
13. Subretinal Fluid in Neovascular AMD: Friend or Foe?

    Publicado: 5/5/2022
14. Optogenetics

    Publicado: 28/4/2022
15. Inhibition of Plasma Kallikrein in Diabetic Macular Edema

    Publicado: 21/4/2022
16. Neovascular AMD: Unpacking Surgical Disease Management Options

    Publicado: 14/4/2022
17. Ocular Therapeutics Sustained Release TKI Trial

    Publicado: 7/4/2022
18. Gene Therapy of nAMD and Diabetic Retinopathy with Dr. Allen Ho

    Publicado: 31/3/2022
19. Long Term Results of the Port Delivery System

    Publicado: 24/3/2022
20. The Altissimo Study using a TKI for nAMD

    Publicado: 17/3/2022